LWCFA
SZYM

Loring Wolcott & Coolidge Fiduciary Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-17,525
Closed -$36K – 662
2016
Q1 		$36K Hold
17,525
– – ﹤0.01% 436
2015
Q4 		$43K Sell
17,525
-8,300
-32% -$24.6K ﹤0.01% 442
2015
Q3 		$81K Hold
25,825
– – ﹤0.01% 375
2015
Q2 		$81K Sell
25,825
-1,000
-4% -$3.43K ﹤0.01% 375
2015
Q1 		$77K Sell
26,825
-2,210
-8% -$5.65K ﹤0.01% 390
2014
Q4 		$75K Sell
29,035
-62,900
-68% -$275K ﹤0.01% 383
2014
Q3 		$686K Buy
91,935
+44,050
+92% +$411K 0.02% 162
2014
Q2 		$564K Buy
47,885
+42,585
+803% +$454K 0.02% 182
2014
Q1 		$62K Buy
+5,300
New +$62.4K ﹤0.01% 395

Loring Wolcott & Coolidge Fiduciary Advisors's SZYM Position: Q2 2016 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 17,525 shares — an estimated $36K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in SZYM in Q1 2014 and held it in 9 quarters. The position peaked at $686K in Q3 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 17,525 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $36K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 9 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's SOLAZYME INC COM STK (DE) position peaked at $686K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2016, filed 11 Jul 2016.